c-Abl Monoclonal Antibody

This gene is a protooncogene that encodes a protein tyrosine kinase involved in a variety of cellular processes, including cell division, adhesion, differentiation, and response to stress. The activity of the protein is negatively regulated by its SH3 domain, whereby deletion of the region encoding this domain results in an oncogene. The ubiquitously expressed protein has DNA-binding activity that is regulated by CDC2-mediated phosphorylation, suggesting a cell cycle function. This gene has been found fused to a variety of translocation partner genes in various leukemias, most notably the t(9;22) translocation that results in a fusion with the 5' end of the breakpoint cluster region gene (BCR; MIM:151410). Alternative splicing of this gene results in two transcript variants, which contain alternative first exons that are spliced to the remaining common exons.

Introducing the C-ABL Monoclonal Antibody, a cutting-edge scientific innovation designed to revolutionize the field of molecular biology. This meticulously crafted product is meticulously engineered to target and bind specifically to the C-ABL protein, enabling researchers to delve deeper into the intricate mechanisms of cellular signaling pathways.

The C-ABL Monoclonal Antibody boasts exceptional specificity and sensitivity, ensuring accurate and reliable results in a wide range of applications. Its high affinity for the C-ABL protein allows for precise detection and quantification, facilitating comprehensive analysis of cellular processes and their dysregulation in various disease states.

Crafted with utmost precision, this antibody exhibits exceptional reproducibility, guaranteeing consistent and robust outcomes across multiple experiments. Its exceptional performance is further enhanced by its compatibility with various experimental techniques, including Western blotting, immunoprecipitation, and immunofluorescence, enabling researchers to explore diverse avenues of investigation.

Moreover, the C-ABL Monoclonal Antibody is manufactured using state-of-the-art techniques and undergoes rigorous quality control measures to ensure utmost purity and reliability. Its formulation is optimized to minimize non-specific binding, thereby reducing background noise and enhancing signal-to-noise ratios, ultimately leading to more accurate and interpretable data.

In addition to its exceptional scientific capabilities, this antibody is packaged in a user-friendly format, allowing for convenient storage and handling. Its long shelf life ensures prolonged usability, making it an indispensable tool for both academic and industrial laboratories.

In summary, the C-ABL Monoclonal Antibody represents a breakthrough in molecular biology research, offering unparalleled specificity, sensitivity, and reproducibility. With its versatility and reliability, this antibody is poised to empower researchers in unraveling the complexities of cellular signaling pathways and advancing our understanding of various diseases.